Aditx Therapeutics Inc

NASDAQ:ADTX   3:59:41 PM EDT
1.95
+0.04 (+2.09%)
Products

Aditx Says AditxtScore Laboratory Operations For Immune Monitoring Secured CLIA Certification

Published: 11/19/2020 13:47 GMT
(ADTX) - Aditx Therapeutics - Aditxtscore Laboratory Operations for Immune Monitoring Secured Clia Certification.
Aditx Therapeutics Inc - Clia Certification, Allows for Launch of Aditxtscore for Covid-19 As a Laboratory Developed Test.
Aditx Therapeutics Inc - Commercial Launch of Aditxtscore for Covid-19 Targeted for January 2021.
Aditx Therapeutics - Plans to Continue to Pursue Eua Application It Submitted to FDA in Late August 2020 for Aditxtscore for Covid-19.